Tuesday, June 21, 2016

BRIEF-OPKO Health says FDA approves new drug application for Rayaldee

* Fda Approves New Drug Application For Rayaldee To Treat

Secondary Hyperparathyroidism Associated With Vitamin D

Insufficiency In Stage 3

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)